The Effect of Thymoma on Remission for Patients Who Undergo Thymectomy for Myasthenia Gravis

흉선절제술을 시행받은 중증근무력증 환자에서 흉선종이 증상 완화에 미치는 효과

  • Kim, Hee-Jung (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Seung-Il (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kang, Seong-Sik (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Eulji University) ;
  • Lee, Eung-Sirk (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University) ;
  • Kim, Yong-Hee (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Bae, Chi-Hoon (Department of Thoracic & Cardiovascular Surgery, School of Medicine, Catholic University of Daegu) ;
  • Kim, Dong-Kwan (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • 김희중 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 박승일 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 강성식 (을지의과대학교 흉부외과학교실) ;
  • 이응석 (성균관대학교 의과대학 삼성서울병원 흉부외과) ;
  • 김용희 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 배지훈 (대구가톨릭대학교 의과대학 흉부외과학교실) ;
  • 김동관 (울산대학교 의과대학 서울아산병원 흉부외과학교실)
  • Published : 2007.11.05

Abstract

Background: Thymoma occurs in approximately 10% of myasthnia gravis patients. The thymus or a thymoma plays a role in the pathogenesis of myasthenia gravis. However, there is currently no definitive position about the effect of thymectomy on patients' symptoms and prognosis. We retrospectively studied the effect of thymoma on re-mission in patients who underwent thymectomy for myasthenia gravis. Material and Method: From July, 1992 to December, 2002, we performed extended thymectomy due to myasthenia gravis for 100 patients. The thymoma group included 30 people, the non-thymoma group included 70 people and the change of the Ossermann stage between the two groups after surgery was compared. Result: For the non-thymoma group, the average age was 34.7 years (range: $12.7{\sim}47.7$). Before the surgical operation, the Ossermann stage for the non-thymoma group was an average of 3.00, and this was reduced to an average of 1.41 after operation. For the thymoma group, the average age was 50.9 years (range: $37.3{\sim}64.5$). Before the surgical operation, the Ossermann stage for the thymoma group was an average of 3.00, and this was reduced to an average of 1.47 after operation. The non-thymoma patients had a higher proportion of males than the thymoma patients (35% vs 30%, respectively), The Masaoka stage was stage of the thymoma group was I for 27 patients and stage II for 3 patients. There was no statistically significant Ossermann stage change between the thymoma and non-thymoma groups. Conclusion: Whether thymoma was present or not, there was no significant difference on remission and improvement of myasthenia symptoms after thymectomy in the myasthenia gravis patients.

배경: 중증근무력증 환자의 약 10% 정도에서 흉선종이 동반된다. 흉선과 흉선종은 중증근무력증의 병태생리에 의미 있는 역할을 한다. 그러나 흉선 절제술 후 환자의 증상과 예후에 흉선종이 미치는 영향에 대해 아직 정립되어 있지 않은 실정이다. 흉선종이 중증근무력증 환자의 증상 관해에 미치는 영향에 대해 후향적으로 연구하였다. 대상 및 방법: 1992년 7월부터 2002년 12월까지 중증근무력증으로 확대 흉선절제술을 시행받은 100명의 환자를 대상으로 하였다. 흉선종군은 30명, 비흉선종군은 70명이었고, 두 군간의 수술 전후 Ossermann병기 변화를 비교하였다. 결과: 비흉선종군은 평균 나이가 34.7 ($12.7{\sim}47.7$)세였다. 그리고, 수술 전 Ossermann 병기는 평균 3.06이었고, 수술 우 평균 1.41로 감소하였다 흉선종군은 평균 나이가 50.9 ($37.3{\sim}64.5$)세였다. 그리고, 수술 전 Ossermann 병기는 평균 3.00이었고, 수술 후 평균 1.47로 감소하였다. 남자의 비율은 흉선종군보다 비흉선종군에서 더 높았다(35% vs 30%). 흉선종의 Masaoka 병기는 1기가 27명, 2기가 3명이었다. 흉선종군과 비 흉선종군 간의 Ossermann 병기 변화는 통계적으로 차이가 없었다(p=0.09). 결론: 흉선종의 유무는 흉선제거술을 시행받은 중증근무력증 증상의 관해나 호전에 영향이 없었다.

Keywords

References

  1. Vincent A, Wilcox N, Hill M, Curnow J, MacLennan C, Beeson D. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev 1998;164:157-68 https://doi.org/10.1111/j.1600-065X.1998.tb01217.x
  2. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357:2122-8 https://doi.org/10.1016/S0140-6736(00)05186-2
  3. Sanders DB, Scoppetta C. The treatment of patients with myasthenia gravis. Neurol Clin North Am 1994;12:343-68 https://doi.org/10.1016/S0733-8619(18)30101-4
  4. Weigert C. Pathologisch-anatomischer Beitrag zur Erbschen Krankheit (Myasthenia gravis). Neurol Zentralbl 1901;20:597-601
  5. Blalock A, Mason MF, Morgan HJ, Riven SS. Myasthenia gravis and tumors of the thymic region: report of a case in which tumor was removed. Ann Surg 1939;110: 554-61
  6. Bril V, Kojic C, Ilse WK, Cooper JD. Long-term Clinical outcome after transcervical thymectomy for myasthenia gravis. Ann Thorac Surg 1998;65:1520-2 https://doi.org/10.1016/S0003-4975(98)00184-2
  7. Masaoka A, Yamakawa Y, Niwa H, et al. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg 1996;62:853-9 https://doi.org/10.1016/S0003-4975(96)00376-1
  8. Budde JM, Morris CD, Gal AA, Mansour KA, Miller JI Jr. Predictors of outcome in thymectomy for myasthenia gravis. Ann Thorac Surg 2001;72:197-202 https://doi.org/10.1016/S0003-4975(01)02678-9
  9. Berrih-Akin S, Morel E, Raimond F. The role of the thymus in myasthenia gravis immunohistological and immunological studies in 115 case. Ann N Y Acad Sci 1987;505:51-70
  10. Wakata N, Fujoka T, Nishina M, Kawamura Y, Kobayashi M, Kinoshia M. Myasthenia gravis and invasive thymoma. Eur Neurol 1993;33:115-20 https://doi.org/10.1159/000116916
  11. Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol 1999;17:2280-9 https://doi.org/10.1200/JCO.1999.17.7.2280
  12. Perrot M, Liu J, Bril V, McRae K, Bezjak A, Keshavjee, SH. Prognostic significance of thymomas in patiens with myasthenia gravis. Ann Thorac Surg 2002;74:1658-62 https://doi.org/10.1016/S0003-4975(02)04083-3
  13. Monden Y, Nakahara K, Nanjo S, et al. Invasive thymoma with myasthenia gravis. Cancer 1984;54:2513-8 https://doi.org/10.1002/1097-0142(19840701)54:1<54::AID-CNCR2820540113>3.0.CO;2-A
  14. KIM DK, Kang SS, Chun MS, et al. Prognostic relevance of WHO classification and masaoka stage in thymoma. Korean J Thorac Cardiovasc Surg 2005;38:44-9